FWM
CLVS

Frontier Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Frontier Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,575
Closed -$160K – 454
2021
Q2 		$160K Buy
27,575
+1
+0% +$6 0.01% 413
2021
Q1 		$194K Buy
+27,574
New +$185K 0.01% 366
2020
Q3 		– Sell
-38,874
Closed -$262K – 376
2020
Q2 		$262K Sell
38,874
-81,300
-68% -$616K 0.02% 293
2020
Q1 		$764K Hold
120,174
– – 0.12% 141
2019
Q4 		$1.25M Buy
+120,174
New +$874K 0.2% 109
2018
Q4 		– Sell
-21,344
Closed -$627K – 412
2018
Q3 		$627K Sell
21,344
-6,916
-24% -$268K 0.06% 196
2018
Q2 		$1.28M Buy
28,260
+1,175
+4% +$57.1K 0.18% 123
2018
Q1 		$1.43M Sell
27,085
-365
-1% -$21.3K 0.2% 117
2017
Q4 		$1.87M Buy
27,450
+4,690
+21% +$328K 0.3% 80
2017
Q3 		$1.88M Buy
22,760
+835
+4% +$66.2K 0.27% 96
2017
Q2 		$2.05M Sell
21,925
-275
-1% -$16.8K 0.31% 85
2017
Q1 		$1.41M Sell
22,200
-875
-4% -$53.2K 0.22% 117
2016
Q4 		$1.02M Sell
23,075
-17,200
-43% -$605K 0.17% 152
2016
Q3 		$1.45M Sell
40,275
-515
-1% -$11K 0.22% 109
2016
Q2 		$560K Sell
40,790
-14,545
-26% -$213K 0.09% 193
2016
Q1 		$1.06M Sell
55,335
-3,860
-7% -$81.7K 0.09% 128
2015
Q4 		$2.07M Sell
59,195
-27,700
-32% -$1.79M 0.33% 83
2015
Q3 		$7.99M Buy
86,895
+13,550
+18% +$1.17M 1.26% 14
2015
Q2 		$6.45M Buy
+73,345
New +$6.28M 0.99% 19

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frontier Wealth Management's CLVS Position: Q3 2021 in Review

Frontier Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2021, closing a stake of 27,575 shares — an estimated $160K sold.

Frontier Wealth Management first reported a position in CLVS in Q2 2015 and held it in 19 quarters. The position peaked at $7.99M in Q3 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • Frontier Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q3 2021 after selling out during the quarter.
  • Frontier Wealth Management sold 27,575 Clovis Oncology, Inc. shares in Q3 2021, an estimated $160K.
  • Frontier Wealth Management first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 19 quarters.
  • Frontier Wealth Management's Clovis Oncology, Inc. position peaked at $7.99M in Q3 2015.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Frontier Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.